The Global Emerging Markets Group
VC Fund
New York, United States
The Global Emerging Markets Group is a VC fund in New York focused on Blockchain and Biotechnology. Global Emerging Markets ("GEM") is an alternative investment group that manages a diverse set of investment vehicles focused on emerging markets across the world.The partners have a century of collective experience . GEM's investment vehicles provide the group and its investors with a diversified portfolio of asset classes that spanthe global private investing spectrum.Each investment vehicle has a different degree of operational control, risk-adjusted return and liquidity profile. Our family of funds and investment vehicles provide GEM and its partners with exposure to: Small-Mid Cap Management Buyouts, Private Investments in Public Equities (PIPEs) and select venture investments. Finally, GEM gets exposure to the United States private equity space with its affiliate fund, Kinderhook Industries, dedicated to mid-cap control buyouts in the United States.
- Total investments:
- 87
- Last investment:
- Lead investor:
- 94%
Last updated:
For AI agents: llms.txt
Industries The Global Emerging Markets Group invests in
Stages The Global Emerging Markets Group invests in
Countries The Global Emerging Markets Group invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Private Equity
- $34M–$250M
- Post-IPO Equity
- $4.7M–$57M
- Venture - Series Unknown
- $18M–$200M
Investment Focus
Industry
- Blockchain 15 (17%)
- Biotechnology 13 (15%)
- Cryptocurrency 10 (11%)
- Software 8 (9%)
- Financial Services 8 (9%)
Stage
- Private Equity 30 (34%)
- Venture - Series Unknown 18 (21%)
- Post-IPO Equity 14 (16%)
- Funding Round 7 (8%)
- Initial Coin Offering 4 (5%)
Country
- United States 25 (29%)
- Switzerland 6 (7%)
- India 5 (6%)
- Canada 5 (6%)
- Singapore 5 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Christopher Brown
Founder & Director
|
Founder & Director | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Senhwa Biosciences
|
Senhwa Biosciences identifies and develops innovative therapies that have the potential to fundamentally change the way patients are treated. Our central philosophy is to unearth validated targets or therapies that could significantly improve treatment, but have not yet been properly exploited. As a value-added development company, Senhwa aims totake innovative therapies that could impact the current standard of care and drive them through to clinical proof-of-concept. | $15.8M / Post-IPO Equity / Apr 14, 2026 | |
FENIX360
|
FENIX360 offers a social media and creator platform that enables artists and creatives to present work, engage directly with fans, and monetize fan interactions across music, video, merchandise, livestreams, and other content channels. It provides tools within a unified app environment for artists to build and customize their own presence, managecontent distribution, and access various revenue streams without relying on external intermediaries. The platform integrates features such as fan engagement, collectible creation, ticketing, and social media management to support creator career activities. FENIX360 also supports partnerships and publishing integrations that broaden opportunities for creators and enhance fan interaction on and off the platform. | $90M / Private Equity / Dec 19, 2025 | |
EDENA Capital Partners
|
EDENA Capital Partners, a Singapore-based firm,pioneers government-approved Security Token Offering (STO) exchange infrastructure to tokenize illiquid real-world assets into regulated digital securities. The platform bridges traditional finance and blockchain, enabling fractional ownership of assets like real estate, corporate equity, carboncredits, government bonds, ETFs, and REITs, with investments accessible from $1-$10 globally. It operates in 4+ countries including Singapore, Cambodia, Malaysia, Indonesia, Korea, and Egypt, covering 2.6 billion people via 8+ partnerships and a $250M+ asset pipeline. | $100M / Dec 18, 2025 | |
Skydrops
|
Skydrops is a bottled water company that produces and supplies aluminum and glass bottles of drinking water. | $26.1M / Venture - Series Unknown / Nov 05, 2025 | |
RareX
|
RareX develops projects to mine rare earth minerals, such as the Cummins Range rare earths project. Electric cars, wind turbines, and military systems all use rare-earth permanent magnets. | $16.5M / Post-IPO Equity / Sep 24, 2025 | |
MoviePass
|
MoviePass is a subscription service that allows customers the freedom to see movies in theaters at a fixed monthly price. With the use of location-based mobile technologies the user will have the ability to check into their movie theater of choice and share their movie-going experiences with their peers through their favorite social networks. Theuser will also have the ability to rate each movie and theater experience after the film. It was founded in 2011 and is headquartered in New York. | $100M / Convertible Note / May 15, 2025 | |
Stramsen Biotech
|
Stramsen Biotech is a biopharmaceutical company that uses natural plant based approach to develop medicines. | $25M / Series B / Apr 07, 2025 | |
Sequana Medical
|
Sequana Medical is a Swiss medical device company providing implantable pump systems to manage fluid balance within the body. This system is designed to move excess fluid to the bladder, where it is passed naturally from the body through normal urination.Sequana Medical’s first product, the Alfapump System, is an innovative solution for themanagement of ascites. Ascites is a fluid that collects in the abdominal cavity in people with advanced liver disease, certain cancers, or congestive heart failure. Alfapump System was the first and only system for the automatic and continual removal of ascites.Sequana Medical was founded in 2006 and is based in Zurich, Switzerland. | Post-IPO Equity / Mar 18, 2025 | |
NEXSTUN
|
Nexstun provides innovative non-lethal options for law enforcement, such as the E-Stunglove, a glove that delivers electric impulses and is intended for personal defense. It aids in managing unstable situations and reducing dangers, as well as temporarily neutralizing threats without inflicting lasting damage. | $47.8M / Series A / Mar 04, 2025 | |
Safe Dynamics
|
Safe Dynamics is an independent safety company that promotes the public’s understanding and acceptance of wireless technologies. It has developed applications and protocols that guarantee workers may perform their tasks safely around RF transmitting antennas. | $100M / Private Equity / Feb 14, 2025 | |
| See all 87 investments → | |||
Co-Investors
GEM Digital
2 deals together
K20 Fund
2 deals together
Global Equity Partners Beteiligungs-Management
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does The Global Emerging Markets Group invest in?
The Global Emerging Markets Group invests primarily in Blockchain, Biotechnology and Cryptocurrency startups, most often at Private Equity and Venture - Series Unknown stage. Most of the 87 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is The Global Emerging Markets Group's check size?
The Global Emerging Markets Group typically joins rounds of $34M–$250M at Private Equity, $4.7M–$57M at Post-IPO Equity and $18M–$200M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds The Global Emerging Markets Group participates in.
How do I contact The Global Emerging Markets Group?
Public channels for The Global Emerging Markets Group include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at The Global Emerging Markets Group?
The team at The Global Emerging Markets Group includes Christopher Brown (Founder & Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
